Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Visco VisionTPE:6782 +6.96%100 Debt-to-Equity is 0.15 as of Jun. 2026, which is 63% below its 10-year median of 0.41. GuruFocus rates TPE:6782 with a GF Score™ of 100/100 and a GF Value™ of NT$250.97 (Fairly Valued). The stock has 1 warning sign investors should review. Among 697 Medical Devices & Instruments companies, Visco Vision ranks better than 61.26% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Visco Vision's Debt-to-Equity or its related term are showing as below:
TPE:6782'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.11 Med: 0.41 Max: 1.29
Current: 0.15
During the past 9 years, the highest Debt-to-Equity Ratio of Visco Vision was 1.29. The lowest was 0.11. And the median was 0.41.
TPE:6782's Debt-to-Equity is ranked better than 61.26% of 697
companies
in the Medical Devices & Instruments industry
Industry Median: 0.24
vs TPE:6782: 0.15
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Visco Vision Debt-to-Equity Related Terms
Visco Vision Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Visco Vision's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6782 vs ISRG, BDX, MDLN: Debt-to-Equity Comparison
For the Medical Instruments & Supplies subindustry, Visco Vision's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Visco Vision Debt-to-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Visco Vision's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Visco Vision's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Visco Vision (TPE:6782) has a Debt-to-Equity of 0.15 as of Jun. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Visco Vision and its competitors. This is 63% below median its historical median of 0.41. Over the past decade, Visco Vision's Debt-to-Equity has ranged from 0.11 to 1.29. According to the industry distribution chart, Visco Vision ranks #270 out of 697 companies in the Medical Devices & Instruments industry, placing it in the top 38.7%.
Is Visco Vision's Debt-to-Equity too high?
Visco Vision's current Debt-to-Equity of 0.15 is 63% below median its 10-year median of 0.41. Over the past 10 years, this metric has ranged from a low of 0.11 to a high of 1.29. The Medical Devices & Instruments industry median Debt-to-Equity is 0.24. Visco Vision's value of 0.15 is 37.5% below this industry median. Based on the distribution chart, Visco Vision ranks #270 out of 697 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Visco Vision has a GF Score™ of 100/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Visco Vision's Debt-to-Equity compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Visco Vision ranks #270 out of 697 companies for Debt-to-Equity. This puts Visco Vision in the upper half of its industry. The industry median Debt-to-Equity is 0.24. Visco Vision's value of 0.15 is 37.5% below this benchmark. Historically, Visco Vision's own Debt-to-Equity has ranged from 0.11 to 1.29 over the past decade. While the company's 10-year median is 0.41 vs. the industry median of 0.24, Visco Vision has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.24, based on 697 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Visco Vision's current Debt-to-Equity of 0.15 is 37.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Visco Vision and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Visco Vision's current Debt-to-Equity is 0.15, which is 63% below median its own 10-year median of 0.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Visco Vision stock overvalued right now?
Based on GuruFocus' analysis, Visco Vision (TPE:6782) is currently considered Fairly Valued. The stock's GF Value™ is NT$250.97, compared to a current price of NT$246.00 — trading 2% below its estimated fair value. The current Debt-to-Equity is 0.15, which is 63% below median its 10-year median of 0.41 and 37.5% below the Medical Devices & Instruments industry median of 0.24. Visco Vision's overall GF Score™ is 100/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Visco Vision (TPE:6782), the current Debt-to-Equity is 0.15 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Visco Vision (TPE:6782) Overvalued in 2026?
Based on GuruFocus' analysis, Visco Vision stock appears to be undervalued.
The current stock price of NT$246.00 is trading 2% below its estimated GF Value™ of NT$250.97.
GuruFocus considers Visco Vision to be Fairly Valued.
Key valuation signals for TPE:6782:
Debt-to-Equity: 0.15 (63% below median its 10-year median of 0.41)
GF Value™: NT$250.97 vs. price of NT$246.00 (2% below fair value)
Industry Position: 37.5% below the Medical Devices & Instruments median (#270 of 697)
No single metric tells the full story. See the TPE:6782 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Visco Vision Inc is a manufacturer and seller of disposable contact lenses. The company manufactures Spherical Lenses, Multifocal lenses, Toric lenses, and Cosmetic lenses. Geographically, the company earns maximum revenue from Asia, followed by Europe, Taiwan, and the Americas.
100GF Score
Get the complete analysis for TPE:6782
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6782 has been successfully added to your 
